Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Regional lymph node irradiation in early breast cancer

Prof Philip Poortmans - Radboud University Medical Center, Nijmegen, The Netherlands
Regional lymph node irradiation in early breast cancer ( Prof Philip Poortmans - Radboud University Medical Center, Nijmegen, The Netherlands )
28 Sep 2015

Hormonal suppression prevents ovarian failure, preserves fertility in women with breast cancer

Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy
Hormonal suppression prevents ovarian failure, preserves fertility in women with breast cancer ( Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy )
28 Sep 2015

Post diagnosis aspirin improves survival in all gastrointestinal cancers

Ms Martine Frouws - Leiden University Medical Center, Leiden, Netherlands
Post diagnosis aspirin improves survival in all gastrointestinal cancers ( Ms Martine Frouws - Leiden University Medical Center, Leiden, Netherlands )
28 Sep 2015

Preventing ovarian failure and preserve fertility in women with breast cancer with hormonal therapy

Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy
Preventing ovarian failure and preserve fertility in women with breast cancer with hormonal therapy ( Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy )
28 Sep 2015

ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review

Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review ( Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK )
28 Sep 2015

PD-L2 expression and its relevance to anti-PD-1 therapy in cancer

Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA
PD-L2 expression and its relevance to anti-PD-1 therapy in cancer ( Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA )
28 Sep 2015

COMBI-V: Melanoma survival improved by targeted drug combination

Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France
COMBI-V: Melanoma survival improved by targeted drug combination ( Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France )
28 Sep 2015

Dabrafenib plus trametinib improves melanoma patients’ survival

Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France
Dabrafenib plus trametinib improves melanoma patients’ survival ( Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France )
28 Sep 2015

Economics of radiotherapy and radiotherapy boost for high grade invasive breast cancer

Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands
Economics of radiotherapy and radiotherapy boost for high grade invasive breast cancer ( Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands )
28 Sep 2015

EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors on long-term local control

Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland
EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors on long-term local control ( Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland )
27 Sep 2015

Cabozantinib improves advanced kidney cancer survival: METEOR trial results

Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Cabozantinib improves advanced kidney cancer survival: METEOR trial results ( Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
27 Sep 2015

Melanoma immunotherapy latest and TVEC plus pembrolizumab

Dr Georgina Long - University of Sydney, Sydney, Australia
Melanoma immunotherapy latest and TVEC plus pembrolizumab ( Dr Georgina Long - University of Sydney, Sydney, Australia )
27 Sep 2015